Samenvatting
Hart- en vaatziekten (HVZ) zijn nog steeds de meest voorkomende oorzaak van sterfte in Nederland en andere geïndustrialiseerde landen. In Nederland overleden in 2006 42.522 personen (gemiddeld 116 personen per dag) aan de gevolgen van een hart- of vaatziekte.
Leesadvies: Atherosclerose
Koek HL, Bruin A de, Gast A, Gevers E, Kardaun JW, Reitsma JB, Grobbee DE, Bots ML. Incidence of first acute myocardial infarction in the Netherlands. Neth J Med 2007;65(11):434–41.
Koenig W, Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27(1):15–26.
Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82(3):265–8.
McMahan CA, McGill HC, Gidding SS, Malcom GT, Newman WP, Tracy RE, Strong JP. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. PDAY risk score predicts advanced coronary artery atherosclerosis in middle-aged persons as well as youth. Atherosclerosis 2007;190(2):370–7.
Smulders YM, Burgers JS, Scheltens T, Hout BA van, Wiersma T, Simoons ML. Guideline development group for the Dutch guideline for multidisciplinary cardiovascular risk management. Clinical practice guideline for cardiovascular risk management in the Netherlands. Neth J Med 2008;66(4):169–74.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92(5):1355–74.
Vaartjes I, Peters RJG, Dis SJ van, Bots ML. Hart- en vaatziekten in Nederland: cijfers over leefstijl- en risicofactoren, ziekte en sterfte. Den Haag: Nederlandse Hartstichting; 2006, 2007, 2008. [www.hartstichting.nl -> hartziekten -> Feiten en Cijfers].
Vaartjes I, Reitsma JB, Bruin A de, Berger-van Sijl M, Bos ML, Breteler MM, Grobbee DE, Bots ML. Incidence of first stroke in The Netherlands. Eur J Neurol 2009, in press.
Vliegenthart R. Non-invasive assessment of coronary calcification. Eur J Epidemiol 2004;19(12):1063–72.
Leesadvies: Erectiestoornissen en hart- en vaatziekten
Billups KL, Bank AJ, Padma-Nathan H, Katz SD, Williams RA. Erectile dysfunction as a harbinger for increased cardiometabolic risk. International Journal of Impotence Research 2008;20(3):236–42.
CBO-richtlijn Cardiovasculair risicomanagement, 2006.
Leusink P, Boer LJ de, Vliet Vlieland CW, Rambharose VR, Sprengers AM, Mogendorff SW, Rijn-Van Kortenhof NMM van. NHG-Standaard Erectiele disfunctie (M87). Huisarts Wet 2008;51(8):381–94.
Schouten BW, Bohnen AM, Bosch JL, Bernsen RM, Deckers JW, Dohle GR, Thomas S. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. International Journal of Impotence Research 2008;20(1):92–9.
Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005;294(23):2996–3002.
Website
Leesadvies: Retinale veneuze occlusie (RVO)
Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006;124(5):726–32.
Cugati S, Wang JJ, Knudtson MD, et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 2007;114(3):520–4.
Martin SC, Butcher A, Martin N, et al. Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 2002;86(7):774–6.
Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities Cardiovascular Health studies. Ophthalmology 2005;112(4):540–7.
Leesadvies: Cardiovasculaire aandoeningen bij allochtonen
Agyemang CO. Ethnic variations in blood pressure and hypertension. [Thesis]. Rotterdam: Erasmus Universiteit; 2005.
Agyemang C, Vaartjes I, Bots M L, van Valkengoed I G, de Munter J S, de Bruin A, Berger-van Sijl M, Reitsma J B, Stronks K. Risk of death after first admission for cardiovascular diseases by country of birth in The Netherlands: a nationwide record-linked retrospective cohort study. Heart (British Cardiac Society) 2009;95(9):747–53.
Bindraban NR. The Cardiovascular Risk Profile of Hindustani and Creole Surinamese in the Netherlands compared to white Dutch people. [Thesis]. Amsterdam: Universiteit van Amsterdam; 2007.
Bos V. Ethnic inequalities in mortality in the Netherlands. [Thesis]. Rotterdam: Erasmus Universiteit; 2005.
Courbage Y, Khlat M. Mortality and causes of death of Moroccans in France, 1979-91. Population 1996;8:59–94.
Ekoé JM, Zimmet P, Williams R. The epidemiology of diabetes mellitus. An international perspective. Chichester: J. Wiley Sons; 2001.
El Fakiri F. Prevention of cardiovascular disease in deprived neighbourhoods. [Thesis]. Rotterdam: Erasmus Universiteit; 2008.
Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475–82.
Manna DR. The validity of guidelines in the treatment of patients with different ethnic backgrounds. [Thesis]. Rotterdam: Erasmus Universiteit; 2006.
McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol 1989;42:597–609.
Middelkoop BJC. Diabetes: a true trouble. Studies on cardiovascular risk, ethnicity, socioeconomic position and intervention possibilities. [Thesis]. Amsterdam: Vrije Universiteit; 2001.
Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1–10.
Uitewaal PJM. Type 2 diabetes mellitus and Turkish immigrants. An educational experiment in general practice. [Thesis]. Rotterdam: Erasmus Universiteit; 2003.
Valkengoed I van, Stronks K. Hart- en vaatziekten bij niet-Westerse allochtonen in Nederland. In Hart- en vaatziekten in Nederland. Cijfers over ziekte en sterfte. Nederlandse Hartstichting, 2007.
Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB. ALLHAT Collaborative Research Group. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 2005;293:1595–1608.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Bohn Stafleu van Loghum, onderdeel van Springer Uitgeverij
About this chapter
Cite this chapter
Bots, M. (2010). 1 Epidemiologische aspecten van atherosclerose. In: van den Meiracker, A., Prins, A. (eds) Vasculaire aandoeningen. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-9572-9_1
Download citation
DOI: https://doi.org/10.1007/978-90-313-9572-9_1
Publisher Name: Bohn Stafleu van Loghum, Houten
Print ISBN: 978-90-313-5544-0
Online ISBN: 978-90-313-9572-9
eBook Packages: Dutch language eBook collection